These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1331799)

  • 1. State-of-the-art analgesics from the agonist-antagonist concept.
    Archer S
    NIDA Res Monogr; 1992; 119():71-5. PubMed ID: 1331799
    [No Abstract]   [Full Text] [Related]  

  • 2. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 3. Selectivity of opioid agonists and antagonists for the various opioid receptor types.
    Takemori AE; Portoghese PS
    Psychopharmacol Bull; 1985; 21(3):464-5. PubMed ID: 2994158
    [No Abstract]   [Full Text] [Related]  

  • 4. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Opiates and their antagonists].
    Langwiński R
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1625-9. PubMed ID: 6089154
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of opioids.
    Martin WR
    Pharmacol Rev; 1983 Dec; 35(4):283-323. PubMed ID: 6144112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1989 Annual Report, evaluation of new compounds for opioid activity.
    Woods JH; Medzihradsky F; Smith CB; Winger GD; France CP
    NIDA Res Monogr; 1989; 95():632-79. PubMed ID: 2561858
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
    Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE
    J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid receptors: development of selective peptidomimetics with agonist or antagonist activity.
    Ronsisvalle G; Pappalardo MS; Spampinato S; Mele A
    Farmaco; 1991 Jan; 46(1 Suppl):171-5. PubMed ID: 1649610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Opioid agonists and antagonists, opioid receptors].
    Holzgrabe U; Nachtsheim C; Siener T; Drosihn S; Brandt W
    Pharmazie; 1997 Jan; 52(1):4-22. PubMed ID: 9082464
    [No Abstract]   [Full Text] [Related]  

  • 11. N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.
    Cheng A; Uyeno E; Polgar W; Toll L; Lawson JA; DeGraw JI; Loew G; Camerman A; Camerman N
    J Med Chem; 1986 Apr; 29(4):531-7. PubMed ID: 3007760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New delta-receptor antagonists.
    Thornber CW; Shaw JS; Miller L; Hayward CF; Morley JS; Timms D; Wilkinson A
    NIDA Res Monogr; 1986; 75():177-80. PubMed ID: 2828968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists.
    Lattin DL; Caviness B; Hudson RG; Greene DL; Raible PK; Richardson JB
    J Med Chem; 1981 Jul; 24(7):903-6. PubMed ID: 6268789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new compounds for opioid activity (1983).
    Woods JH; Winger GD; Medzihradsky F; Smith CB; Katz JL
    NIDA Res Monogr; 1984 Mar; 49():361-7. PubMed ID: 6090918
    [No Abstract]   [Full Text] [Related]  

  • 16. [Structure-activity relationship of synthetic and semisynthetic opioid agonists and antagonists].
    Hosztafi S; Friedmann T; Furst Z
    Acta Pharm Hung; 1993 Nov; 63(6):335-49. PubMed ID: 8116454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opiates, opioid receptors and thermoregulatory changes].
    Ovcharov R; Iakimova K
    Eksp Med Morfol; 1984; 23(4):205-10. PubMed ID: 6098438
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid receptors and their subtypes: focus on peripheral isolated tissue preparations.
    Traynor JR
    Neurochem Int; 1994 May; 24(5):427-32. PubMed ID: 7647697
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of two basic nitrogen atoms in 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives in production of opioid agonist and antagonist activities.
    Natsuka K; Nishikawa Y; Nakamura H
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1790-3. PubMed ID: 10748722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.